Feature Clearmind spearheading novel, life-changing psychedelic solutions for binge behaviors and mental health Clearmind Medicine (NASDAQ:CMND; FSE:CWY0) is discovering and developing safe, novel psychedelic-derived therapeutic candidates with its new psychoactive molecule, 5-Methoxy-2-aminoindane (MEAI), to address widespread... November 26, 2024